Upper GI 2017

 Preoperative Chemoradiation  Planned Esophagectomy

• Propensity score match

442 ptz available multi-center (10 Europe)

resectable Esophageal or GEJ Siewert type I and II (stage II or III) , adenocarcinoma 100%

• 3-year overall survival 57.9% versus 53.4%;

HR= 0.89, 95%C.I. 0.67-1.17, p = 0.391

• disease-free survival 52.9% versus 48.9%; HR = 0.90, 95%C.I. 0.69-1.18, p = 0.443

Evaluation period 2001-2012; follow-up until 2015

Markar SR et al – Ann Oncol - 2016 (Ireland)